NM_003640.5:c.934G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003640.5(ELP1):​c.934G>A​(p.Glu312Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0221 in 1,613,956 control chromosomes in the GnomAD database, including 478 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 43 hom., cov: 33)
Exomes 𝑓: 0.022 ( 435 hom. )

Consequence

ELP1
NM_003640.5 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 3.65

Publications

17 publications found
Variant links:
Genes affected
ELP1 (HGNC:5959): (elongator acetyltransferase complex subunit 1) The protein encoded by this gene is a scaffold protein and a regulator for three different kinases involved in proinflammatory signaling. The encoded protein can bind NF-kappa-B-inducing kinase and I-kappa-B kinases through separate domains and assemble them into an active kinase complex. Mutations in this gene have been associated with familial dysautonomia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
ELP1 Gene-Disease associations (from GenCC):
  • primary dysautonomia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Riley-Day syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025151968).
BP6
Variant 9-108916228-C-T is Benign according to our data. Variant chr9-108916228-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0211 (3212/152316) while in subpopulation NFE AF = 0.0247 (1678/68028). AF 95% confidence interval is 0.0237. There are 43 homozygotes in GnomAd4. There are 1576 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 43 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELP1NM_003640.5 linkc.934G>A p.Glu312Lys missense_variant Exon 10 of 37 ENST00000374647.10 NP_003631.2
ELP1NM_001318360.2 linkc.592G>A p.Glu198Lys missense_variant Exon 10 of 37 NP_001305289.1
ELP1XM_047423991.1 linkc.934G>A p.Glu312Lys missense_variant Exon 10 of 25 XP_047279947.1
ELP1NM_001330749.2 linkc.-114G>A 5_prime_UTR_variant Exon 8 of 35 NP_001317678.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELP1ENST00000374647.10 linkc.934G>A p.Glu312Lys missense_variant Exon 10 of 37 1 NM_003640.5 ENSP00000363779.5

Frequencies

GnomAD3 genomes
AF:
0.0210
AC:
3200
AN:
152198
Hom.:
42
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0224
Gnomad AMI
AF:
0.0132
Gnomad AMR
AF:
0.0136
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00829
Gnomad FIN
AF:
0.0238
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0247
Gnomad OTH
AF:
0.0177
GnomAD2 exomes
AF:
0.0189
AC:
4765
AN:
251452
AF XY:
0.0192
show subpopulations
Gnomad AFR exome
AF:
0.0223
Gnomad AMR exome
AF:
0.00737
Gnomad ASJ exome
AF:
0.0111
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0243
Gnomad NFE exome
AF:
0.0279
Gnomad OTH exome
AF:
0.0197
GnomAD4 exome
AF:
0.0223
AC:
32522
AN:
1461640
Hom.:
435
Cov.:
31
AF XY:
0.0215
AC XY:
15645
AN XY:
727138
show subpopulations
African (AFR)
AF:
0.0214
AC:
716
AN:
33480
American (AMR)
AF:
0.00740
AC:
331
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0122
AC:
320
AN:
26132
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39694
South Asian (SAS)
AF:
0.00750
AC:
647
AN:
86252
European-Finnish (FIN)
AF:
0.0238
AC:
1269
AN:
53418
Middle Eastern (MID)
AF:
0.0107
AC:
62
AN:
5768
European-Non Finnish (NFE)
AF:
0.0252
AC:
28029
AN:
1111784
Other (OTH)
AF:
0.0189
AC:
1143
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
1583
3166
4748
6331
7914
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1012
2024
3036
4048
5060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0211
AC:
3212
AN:
152316
Hom.:
43
Cov.:
33
AF XY:
0.0212
AC XY:
1576
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0226
AC:
941
AN:
41574
American (AMR)
AF:
0.0136
AC:
208
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0118
AC:
41
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.00829
AC:
40
AN:
4824
European-Finnish (FIN)
AF:
0.0238
AC:
253
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0247
AC:
1678
AN:
68028
Other (OTH)
AF:
0.0175
AC:
37
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
170
340
509
679
849
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0240
Hom.:
212
Bravo
AF:
0.0200
TwinsUK
AF:
0.0232
AC:
86
ALSPAC
AF:
0.0270
AC:
104
ESP6500AA
AF:
0.0211
AC:
93
ESP6500EA
AF:
0.0226
AC:
194
ExAC
AF:
0.0204
AC:
2483
Asia WGS
AF:
0.00693
AC:
24
AN:
3478
EpiCase
AF:
0.0240
EpiControl
AF:
0.0202

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial dysautonomia Benign:4
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Apr 14, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 18, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Mar 28, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 03, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.032
T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.47
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.64
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
PhyloP100
3.6
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.69
N
REVEL
Benign
0.048
Sift
Benign
0.36
T
Sift4G
Benign
0.50
T
Polyphen
0.075
B
Vest4
0.050
MPC
0.10
ClinPred
0.016
T
GERP RS
4.7
Varity_R
0.046
gMVP
0.18
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1140064; hg19: chr9-111678508; API